1.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: CPP-450, 2010-019140-39, NCT01317433
|
|
2.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 2011-1165, NCT01590082
|
|
3.
|
Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: E-VITA, NCT01345526
|
|
4.
|
Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2008362-01H, NCT01411202
|
|
5.
|
Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: GMIHO-010/2009, NCT01418742
|
|
6.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Natural history/Epidemiology Status: Active Age: 2 to 40 Sponsor: NCI Protocol IDs: 120159, 12-C-0159, NCT01631617
|
|
7.
|
Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 and Sponsor: Other Protocol IDs: AIO-LQ-0110, 2010-022938-85, NCT01668498
|
|
8.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: IELSG39, NCT01820910
|
|
9.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Natural history/Epidemiology Status: Active Age: 8 and over Sponsor: NCI Protocol IDs: NCI-06-C-0198, NCI-P6963, NCT00411008
|